Login / Signup

Loss of hepatic Mboat7 leads to liver fibrosis.

Veera Raghavan ThangapandiOskar KnittelfelderMario BroschEleonora PatsenkerOlga VvedenskayaStephan BuchSebastian HinzAlexander HendricksMarina NatiAlexander HerrmannDevavrat Ravindra RekhadeThomas BergMadlen Matz-SojaKlaus HuseEdda KlippJosch K PaulingJudith Ah WodkeJacobo Miranda AckermanMalte von BoninElmar AignerChristian DatzWitigo von SchönfelsSophie NehringSebastian ZeissigChristoph RoeckenAndreas DahlTriantafyllos ChavakisFelix StickelAndrej ShevchenkoClemens SchafmayerJochen HampePallavi Subramanian
Published in: Gut (2020)
Mboat7 deficiency in mice and human points to an inflammation-independent pathway of liver fibrosis that may be mediated by lipid signalling and a potentially targetable treatment option in NAFLD.
Keyphrases
  • liver fibrosis
  • endothelial cells
  • oxidative stress
  • replacement therapy
  • induced pluripotent stem cells
  • high fat diet induced
  • combination therapy
  • metabolic syndrome
  • adipose tissue